Trials / Completed
CompletedNCT00043901
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects Wtih Primary Generalized Tonic-Clonic Seizures
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness and safety of an investigational new drug for supplemental therapy in subjects with primary generalized tonic-clonic (PGTC) seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lamotrigine |
Timeline
- Start date
- 2000-12-01
- Primary completion
- 2003-11-01
- Completion
- 2005-03-01
- First posted
- 2002-08-16
- Last updated
- 2017-04-04
Locations
87 sites across 4 countries: United States, Argentina, Chile, Peru
Source: ClinicalTrials.gov record NCT00043901. Inclusion in this directory is not an endorsement.